Weekly Intelligence · 6 articles
Vet Industry Intel: Nov 9 – Nov 15, 2025
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Acquisitions & M&A
Zoetis agreed diagnostic firm deal
Zoetis announced an agreement to acquire or partner with a diagnostic firm, expanding its presence in veterinary diagnostics.
Zoetis
Inspire Veterinary Partners Signs Exclusive, Non-Binding Letter of Intent to Acquire New Jersey Animal Hospital
Inspire Veterinary Partners has signed an exclusive, non-binding letter of intent to acquire an animal hospital located in New Jersey.
Inspire Veterinary Partners | NJ
Regulatory & Policy
FDA Completes Safety for Gallant's First Ready-to-Use Stem Cell Therapy for Refractory FCGS
The FDA has completed safety reviews for Gallant's first ready-to-use stem cell therapy intended for refractory feline chronic gingivostomatitis (FCGS).
FDA · Gallant · PR Newswire
FDA issues first-ever emergency use authorization for drug to combat screwworm in dogs
The FDA has issued its first-ever emergency use authorization for a drug designed to combat screwworm in dogs.
FDA · American Veterinary Medical Association
Response of United States to Public Comments on the Proposed Final Judgment
The Department of Justice has released its response to public comments regarding a proposed final judgment. This indicates a regulatory process is underway, likely related to antitrust or competition within the veterinary industry.
Department of Justice
FDA reminds pet food makers that raw ingredients pose risk of exposure to H5N1
The FDA issued a reminder to pet food manufacturers regarding the risk of H5N1 exposure from raw ingredients.
FDA · American Veterinary Medical Association
Most-mentioned this week
Inspire Veterinary Partners (1)